| ［1］ |
Ben Lagha I, Ashack K, Khachemoune A. Hailey⁃Hailey disease: an update review with a focus on treatment data［J］. Am J Clin Dermatol, 2020,21（1）:49⁃68. doi: 10.1007/s40257⁃019⁃00477⁃z.
|
| ［2］ |
Alamon⁃Reig F, Serra⁃García L, Bosch⁃Amate X, et al. Dupilumab in Hailey⁃Hailey disease: a case series［J］. J Eur Acad Dermatol Venereol, 2022,36（10）:e776⁃e779. doi: 10.1111/jdv.18350.
|
| ［3］ |
Alzahrani N, Grossman⁃Kranseler J, Swali R, et al. Hailey⁃Hailey disease treated with dupilumab: a case series［J］. Br J Dermatol, 2021,185（3）:680⁃682. doi: 10.1111/bjd.20475.
|
| ［4］ |
Licata G, Buononato D, Calabrese G, et al. A case of Hailey⁃Hailey disease successfully treated with dupilumab［J］. Int J Dermatol, 2022,61（11）:1427⁃1428. doi: 10.1111/ijd.16322.
|
| ［5］ |
Deng H, Xiao H. The role of the ATP2C1 gene in Hailey⁃Hailey disease［J］. Cell Mol Life Sci, 2017,74（20）:3687⁃3696. doi: 10.1007/s00018⁃017⁃2544⁃7.
|
| ［6］ |
Yoto A, Makino T, Mizawa M, et al. Two cases of Hailey⁃Hailey disease effectively treated with apremilast and a review of reported cases［J］. J Dermatol, 2021,48（12）:1945⁃1948. doi: 10.1111/1346⁃8138.16178.
|
